Rare diseases
Investigational molecules
Locations
Diakonissenstrasse 8, Mitte, 58455 Witten, Germany
KliFoCenter GmbH in Witten, Germany specialises in clinical trials of conditions such as Obesity, Type 2 diabetes mellitus, Respiratory syncytial virus infection, Respiratory syncytial virus bronchiolitis, and other specialisations. This site conducts important research.
The KliFoCenter GmbH focuses on atherosclerotic cardiovascular disease and related conditions, aiming to test new therapies that lower the risk of heart attacks, strokes, and other serious events. Trials compare innovative agents with standard anticoagulants to improve safety and effectiveness for patients with atrial fibrillation and high lipid risk.
These studies at KliFoCenter aim to bring safer, more effective treatments to people at elevated cardiovascular risk.
In the metabolic field, the centre investigates therapies for obesity and weight‑related health issues, evaluating how novel compounds enhance weight loss when combined with diet and exercise. The goal is to demonstrate superior outcomes compared with placebo for individuals without type‑2 diabetes.
The research supports new options for managing obesity and improving metabolic health at KliFoCenter.
Clinical trials currently enrolling participants at this site.
GermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
